How should insulin glargine (long‑acting) and insulin glulisine (rapid‑acting) be prescribed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Prescribe Insulin Glargine and Insulin Glulisine

Start insulin glargine at 0.1-0.2 units/kg once daily (or 10 units if insulin-naive type 2 diabetes), administered subcutaneously at the same time each day, then add insulin glulisine 4 units before the largest meal when A1C remains above goal, titrating both insulins based on glucose monitoring to achieve target glycemic control. 1, 2

Initial Dosing of Insulin Glargine (Basal Insulin)

For Type 2 Diabetes (Insulin-Naive)

  • Start with 10 units once daily OR 0.1-0.2 units/kg once daily 1, 2
  • Administer subcutaneously at any time of day but must be at the same time every day 2
  • Inject into abdominal area, thigh, or deltoid, rotating sites within the same region 2

For Type 1 Diabetes

  • Start with approximately one-third of total daily insulin requirements 2
  • Must use concomitantly with short-acting insulin (like glulisine) to cover the remaining two-thirds 2

Titration Algorithm for Glargine

  • Increase by 2 units every 3 days to reach fasting plasma glucose goal without hypoglycemia 1
  • Set individualized fasting plasma glucose target based on patient factors 1
  • If hypoglycemia occurs without clear cause, reduce dose by 10-20% 1

Adding Insulin Glulisine (Prandial Insulin)

When to Add Glulisine

  • Add when A1C remains above goal despite optimized basal insulin (glargine) 1
  • Look for clinical signals of overbasalization: elevated bedtime-to-morning glucose differential, postprandial glucose excursions, hypoglycemia, or high glucose variability 1

Initial Dosing of Glulisine

  • Start with 4 units before the largest meal or the meal with greatest postprandial glucose excursion 1
  • Alternative calculation: 10% of the basal insulin dose 1
  • Administer immediately before meals 3, 4

Titration of Glulisine

  • Increase by 1-2 units or 10-15% of the insulin dose based on postprandial glucose readings 1
  • If hypoglycemia occurs, reduce corresponding dose by 10-20% 1
  • When adding glulisine to glargine, consider reducing glargine by 4 units or 10% if A1C <8% to prevent hypoglycemia 1

Stepwise Intensification Approach

Single Daily Glulisine (Basal-Plus)

  • Start with one injection of glulisine before the largest meal 1, 4
  • This simplified approach provides equivalent glycemic control whether given at breakfast or main meal, though main meal may achieve slightly better A1C targets (52.2% vs 36.5% reaching A1C ≤7.0%) 4

Multiple Daily Glulisine (Basal-Bolus)

  • If A1C remains above goal with single glulisine dose, add glulisine before each meal 1
  • Proceed to full basal-bolus regimen with glulisine administered before breakfast, lunch, and dinner 1
  • This provides better glycemic control than premixed insulins, with mean glucose approximately 22-31 mg/dL lower after 4-7 days of therapy 3

Critical Administration Details

Do NOT Mix or Dilute

  • Never mix glargine with any other insulin or solution 2
  • Administer as separate injections from glulisine 2

Route of Administration

  • Subcutaneous only - do not administer intravenously or via insulin pump 2
  • Rotate injection sites within the same anatomical region to prevent lipodystrophy 2

Monitoring Requirements

  • Increase frequency of blood glucose monitoring during any insulin regimen changes 2
  • Monitor fasting glucose to titrate glargine 1
  • Monitor postprandial glucose to titrate glulisine 1

Safety Considerations

Hypoglycemia Risk

  • Hypoglycemia rates are comparable between glargine/glulisine combinations and other regimens (0.10-0.14 episodes per day) 5, 3
  • The combination may actually reduce nocturnal hypoglycemia compared to NPH-based regimens 6
  • When switching from twice-daily NPH to glargine, start at 80% of total NPH dose to reduce hypoglycemia risk 1, 2

Weight Considerations

  • Weight gain is typically minimal and non-significant with glargine/glulisine regimens 5
  • If weight is a concern, consider GLP-1 receptor agonist (like lixisenatide) instead of glulisine, which achieves similar glycemic control with less hypoglycemia and weight gain 7

Common Pitfalls to Avoid

  • Do not underdose glargine - ensure adequate basal coverage before adding prandial insulin 1
  • Do not continue overbasalization - if bedtime-to-morning glucose differential is high or hypoglycemia occurs, add prandial insulin rather than increasing glargine further 1
  • Do not forget to reduce glargine when adding glulisine if A1C is already <8% 1
  • Do not share pens or needles between patients due to blood-borne pathogen transmission risk 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.